Rivard Paul
Known title: EVP of Operations, GCCIK: 0001857479
Rivard Paul's purchase track record
How the stock did after each of Rivard Paul's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since November 23, 2021
Stock higher 6 months later
33%
3 months: 33%
Median 6-month return
-60.4%
3 months: -32.2%
Beat the S&P 500
0%
median -44.4% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/17/2023 | QCLS | $195K | -73.3% | -90.3% | +15.1% |
| 12/8/2022 | QCLS | $15K | +22.1% | +0.6% | +8.3% |
| 11/23/2021 | QCLS | $90K | -32.2% | -60.4% | -16.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| QCLS | ▲ Buy | Open Market | 150,000 | $167K | 8/24/2023 | View on chart |
| QCLS | ▲ Buy | Open Market | 25,000 | $28K | 8/17/2023 | View on chart |
| QCLS | ▲ Buy | Open Market | 10,000 | $15K | 12/8/2022 | View on chart |
| QCLS | ▲ Buy | Open Market | 15,000 | $90K | 11/23/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Rosenblatt initiates coverage on Securitize with Buy rating
Securitize shares rose after Rosenblatt started tracking the stock with a Buy rating and a $14 price target. This analyst action provides new external validation for the company, which is currently trading near the lower end of its 52-week range.
Rosenblatt initiates coverage on Securitize with Buy rating. Securitize shares rose after Rosenblatt started tracking the stock with a Buy rating and a $14 price target. This analyst action provides new external validation for the company, which is currently trading near the lower end of its 52-week range.